Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandro Gronchi

Showing results (291-300 of 486) with videos related to

Pageof 49
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 6, 2007
Cyclooxygenase-2 and platelet-derived growth factor receptors as potential targets in treating aggressive fibromatosisStefano Signoroni, Milo Frattini, Tiziana Negri, et al.
Journal of Surgical Oncology|August 19, 2024
Extent of macroscopic vascular invasion predicts distant metastasis in primary leiomyosarcoma of the inferior vena cavaWilliam W Tseng, Francesco Barretta, Marco Fiore, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 27, 2026
Any impact of pre-operative radiotherapy on renal function in retroperitoneal soft tissue sarcomas? A secondary ancillary analysis of the EORTC 62092 STRASS 1 trialCecile Le Pechoux, Claudia Sangalli, Felix Boakye Oppong, et al.
Oncotarget|August 14, 2014
Identification of a gene expression driven progression pathway in myxoid liposarcomaLoris De Cecco, Tiziana Negri, Silvia Brich, et al.
Genes, Chromosomes & Cancer|June 15, 2018
Novel intra-genic large deletions of CTNNB1 gene identified in WT desmoid-type fibromatosisChiara Colombo, Milena Urbini, Annalisa Astolfi, et al.
British Journal of Cancer|February 13, 2020
Correction: Establishment and characterisation of a new patient-derived model of myxoid liposarcoma with acquired resistance to trabectedinEzia Bello, Silvia Brich, Ilaria Craparotta, et al.
British Journal of Cancer|August 15, 2019
Establishment and characterisation of a new patient-derived model of myxoid liposarcoma with acquired resistance to trabectedinEzia Bello, Silvia Brich, Ilaria Craparotta, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 15, 2012
Phase II study of imatinib in advanced chordomaSilvia Stacchiotti, Alessandra Longhi, Virginia Ferraresi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 27, 2013
Outcome prediction in primary resected retroperitoneal soft tissue sarcoma: histology-specific overall survival and disease-free survival nomograms built on major sarcoma center data setsAlessandro Gronchi, Rosalba Miceli, Elizabeth Shurell, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|March 7, 2021
Complete pathological response to neoadjuvant treatment is associated with better survival outcomes in patients with soft tissue sarcoma: Results of a retrospective multicenter studySylvie Bonvalot, Jay Wunder, Alessandro Gronchi, et al.
Pageof 49

Showing results (291-300 of 486) with videos related to

Sort By:
Pageof 49
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 6, 2007
Cyclooxygenase-2 and platelet-derived growth factor receptors as potential targets in treating aggressive fibromatosisStefano Signoroni, Milo Frattini, Tiziana Negri, et al.
Journal of Surgical Oncology|August 19, 2024
Extent of macroscopic vascular invasion predicts distant metastasis in primary leiomyosarcoma of the inferior vena cavaWilliam W Tseng, Francesco Barretta, Marco Fiore, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 27, 2026
Any impact of pre-operative radiotherapy on renal function in retroperitoneal soft tissue sarcomas? A secondary ancillary analysis of the EORTC 62092 STRASS 1 trialCecile Le Pechoux, Claudia Sangalli, Felix Boakye Oppong, et al.
Oncotarget|August 14, 2014
Identification of a gene expression driven progression pathway in myxoid liposarcomaLoris De Cecco, Tiziana Negri, Silvia Brich, et al.
Genes, Chromosomes & Cancer|June 15, 2018
Novel intra-genic large deletions of CTNNB1 gene identified in WT desmoid-type fibromatosisChiara Colombo, Milena Urbini, Annalisa Astolfi, et al.
British Journal of Cancer|February 13, 2020
Correction: Establishment and characterisation of a new patient-derived model of myxoid liposarcoma with acquired resistance to trabectedinEzia Bello, Silvia Brich, Ilaria Craparotta, et al.
British Journal of Cancer|August 15, 2019
Establishment and characterisation of a new patient-derived model of myxoid liposarcoma with acquired resistance to trabectedinEzia Bello, Silvia Brich, Ilaria Craparotta, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 15, 2012
Phase II study of imatinib in advanced chordomaSilvia Stacchiotti, Alessandra Longhi, Virginia Ferraresi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 27, 2013
Outcome prediction in primary resected retroperitoneal soft tissue sarcoma: histology-specific overall survival and disease-free survival nomograms built on major sarcoma center data setsAlessandro Gronchi, Rosalba Miceli, Elizabeth Shurell, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|March 7, 2021
Complete pathological response to neoadjuvant treatment is associated with better survival outcomes in patients with soft tissue sarcoma: Results of a retrospective multicenter studySylvie Bonvalot, Jay Wunder, Alessandro Gronchi, et al.
Pageof 49